Deprescribing Glucose-Lowering Therapy in Older Adults with Diabetes: A Systematic Review of Recommendations-Reference-Cited by-同舟云学术

Deprescribing Glucose-Lowering Therapy in Older Adults with Diabetes: A Systematic Review of Recommendations

Published:2023-03 Issue:3 Volume:24 Page:400-402
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Christiaens Antoine^ORCID,Henrard Séverine,Sinclair Alan J.,Tubach Florence,Bonnet-Zamponi Dominique,Zerah Lorène

Funder

Wallonie-Bruxelles International

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference10 articles.

1. Benefits and harms of deprescribing antihyperglycemics for adults with type 2 diabetes: A systematic review;Deng;Can J Diabetes,2022

2. Individualisation of glycaemic management in older people with type 2 diabetes: A systematic review of clinical practice guidelines recommendations;Christiaens;Age Ageing,2021

3. Overtreatment of older people with type 2 diabetes-a high impact frequent occurrence in need of a new definition;Christiaens;Diabet Med,2022

4. AGREE II: advancing guideline development, reporting and evaluation in health care;Brouwers;J Clin Epidemiol,2010

5. Essential Steps in Primary Care Management of Older People with Type 2 Diabetes–A Position Statement on behalf of the European Geriatric Medicine Society (EuGMS) and the European Diabetes Working Party for Older People;Bourdel Marchasson,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacto de una unidad de farmacia de atención primaria en la optimización del tratamiento farmacológico de pacientes diabéticos tipo 2;Atención Primaria;2024-09

2. Management of older adults with diabetes mellitus: Perspective from geriatric medicine;Journal of Diabetes Investigation;2024-08-08

3. Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach;Expert Review of Clinical Pharmacology;2024-08-02

4. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation;BMC Primary Care;2024-06-11

5. Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review;Journal of the American Medical Directors Association;2024-03